(File photo.)
  • Cineplex (TSX:CGX) reported box office revenues of C$55.3 million for May 2025, marking a significant 169 per cent increase compared to Q2 2024
  • The theatre chain pointed to the momentum gained from a record-breaking April continued into May with more major titles with Final Destination: Bloodlines scoring a franchise-best domestic box office after just three weeks
  • Revenue for Q2 2025 has amounted to C$63.1 million
  • Cineplex stock (TSX:CGX) last traded at C$11.48

Cineplex (TSX:CGX) reported box office revenues of C$55.3 million for May 2025, marking a significant 163 per cent increase compared to February 2024.

In a media release, the theatre chain pointed to the momentum gained from a record-breaking April continued into May thanks to more major titles with Final Destination: Bloodlines scoring a franchise-best domestic box office after just three weeks; Lilo & Stitch,  set a new record for the biggest May opening for a live-action remake; and Mission: Impossible – the Final Reckoning, which opened to the highest domestic box office in the franchise’s history. If there’s one thing Tom Cruise needs, it’s more money.

Two movies with “final” in the title that probably won’t be the final installment in either franchise, and a remake, were the best-of-the-best last month, a “breadth of titles” according to Cineplex’s president and CEO, Ellis Jacob, that represents the “diverse films” the box office has to offer.

“The strength of content continues in June with the live action adaptation of How to Train Your DragonElio28 Years Later and Apple’s F1: The Movie,” he added, referring to another live-action remake, another sequel, and a fictional story about F1 racing.

To be fair, compare to last year, May 2024’s top films at Cineplex were and sequel and a remake (Kingdom of the Planet of the Apes), a movie based on an old TV show (The Fall Guy), and a sequel (prequel?) in a quasi-reboot (Furiosa: A Mad Max Saga).

Cineplex Inc. is a household Canadian brand active in the film entertainment and content, amusement and leisure and media sectors. It operates more than 169 movie theatres and entertainment venues across the country.

Cineplex stock (TSX:CGX) last traded at C$11.48 and though it has lost 5.90 per cent since the year began, it has risen 55.14 per cent since this time last year.

Join the discussion: Find out what everybody’s saying about this movie theatre stock’s online booking fee on the Cineplex Inc. Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online

@ the Bell: TSX reaches new highs despite oil weakness

Despite a muted performance among the broader market, the TSX climbed to a new historic high...

Alchemy signs development deal to camouflage Canadian troops

Alchemy Labs signs a contract to deploy its Crypsis thermal signature management technology into products for the Canadian defense market.
TSX and Nasdaq rise as Nebius jumps on AI demand. Air Canada cuts guidance, Cerebras falls, oil drops, gold slips and Bitcoin edges higher.

Market Open: Nebius Soars on AI Demand, Air Canada Cuts Guidance as Fuel Costs Bite | Aug 13th

TSX and Nasdaq rise as Nebius jumps on AI demand. Air Canada cuts guidance, Cerebras falls, oil drops, gold slips and Bitcoin edges higher.

Cannabis microcap posts potent Q2 results

MediPharm Labs (TSX:LABS), a cannabis-focused pharma company, elevated into positive net income in Q2 2026.